Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
4.790
+0.400 (9.11%)
Mar 31, 2025, 3:27 PM EDT - Market open
Basel Medical Group Revenue
In the fiscal year ending June 30, 2024, Basel Medical Group had annual revenue of 10.07M SGD with 3.32% growth. Basel Medical Group had revenue of 4.98M in the half year ending June 30, 2024.
Revenue (ttm)
10.07M SGD
Revenue Growth
+3.32%
P/S Ratio
9.96
Revenue / Employee
314,704 SGD
Employees
32
Market Cap
88.40M undefined
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 10.07M | 323.64K | 3.32% |
| Jun 30, 2023 | 9.75M | -911.62K | -8.55% |
| Jun 30, 2022 | 10.66M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBMGL News
- 11 days ago - Basel Medical Group Ltd Announces Exercise of Overallotment Option - GlobeNewsWire
- 4 weeks ago - Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering - GlobeNewsWire
- 4 weeks ago - U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline - Seeking Alpha
- 4 weeks ago - Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering - GlobeNewsWire
- 7 months ago - Singapore health care practice Basel Medical Group files for a $6 million US IPO - Renaissance Capital
- 7 months ago - Basel Medical Group IPO Registration Document (F-1) - SEC